Blogs about: Ctic
Featured Blog
Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)
Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. It often traded huge volume around drug approval or study news, and shares rose after being halted… more →
24/7 Wall St.
Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)
wrote 2 weeks ago: Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be. … more →
24/7 Wall St. Closing Bell (BAC, CHK, SAM, ERJ, PAA, GE, MCD, KMB, ALK, ALTR, COF, HBI, SNDK, KEY, AEP, CP, CTIC, RCL, PCX, RVBD, RMBS)
wrote 1 month ago: Markets opened higher this morning although a decline in tech stocks weighed on the Nasdaq, leaving … more →
24/7 Wall St. Closing Bell (AAPL, ADP, KFT, PG, MCO, LULU, ADGF, CHTP, AEO, BWS, CSIQ, CTIC, HOV, TRCR, MAG, BONT, P, VRML)
wrote 2 months ago: US stocks opened higher this morning following an in-line report from ADP on US employment gains. Th … more →
24/7 Wall St. Closing Bell (CHK, WYN, CMCSA, RL, DELL, CEG, ENB, SPWR, HNZ, CPB, DMD, BDCO, CTIC, GILD, SCON)
wrote 3 months ago: US stocks opened mixed this morning, with the Nasdaq opening lower than both the DJIA and the S& … more →
Morning Movers (CTIC, RAIL, GILD, SCON, SPWR, STP, FSLR)
wrote 3 months ago: Two of the three major US equities indexes opened higher this morning with the Nasdaq composite bein … more →
Cell Therapeutics Finds An Ally (CTIC)
wrote 3 months ago: Cell Therapeutics, Inc. (NASDAQ: CTIC) is getting a major boost this morning, but the move is from n … more →
Is Cell Therapeutics At Death's Door? (CTIC)
wrote 3 months ago: Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial as a stock can get in biotech. Now … more →
24/7 Wall St. Closing Bell (K, SPLS, TWX, AAP, AZO, JPM, GCI, SIFY, WEN, ONB, GTXI, PBY, TNB, CTIC, PMC)
wrote 3 months ago: All three major indexes opened lower again today on weak markets in both Europe and Asia. European m … more →
Mid-Afternoon Movers (GTXI, PBY, TNB, CTIC, PMC)
wrote 3 months ago: At mid-afternoon, we’ve seen some changes among today’s big movers. On the plus side are GTX Inc. (N … more →
Morning Movers (GTXI, PBY, TNB, CTIC, PMC)
wrote 3 months ago: There are several stocks trading more heavily than usual this morning, and also experiencing large g … more →
Morning Movers (LIVE, CTIC, ADGE, CSKI, BONE)
wrote 5 months ago: There are several stocks trading more heavily than usual this morning, and also experiencing large g … more →
24/7 Wall St. Closing Bell (C, SHLD, SIRI, YHOO, MCP, FGP, TITN, OPTT, KMGB, DMND, BCSI, FLOW, PCYC, CTIC, GE)
wrote 5 months ago: Equity markets opened higher this morning as an agreement on dealing with the Eurozone’s debt crisis … more →
Morning Movers (BCSI, CTIC, DD, PCYC, FLOW)
wrote 5 months ago: There are several stocks trading more heavily than usual this morning, and also experiencing large g … more →
24/7 Wall St. Closing Bell (MO, VZ, TSO, LNKD, GE, CHKR, BTH, PBY, UEC, AZO, DRI, TOL, LQDT, DMND, SAI, VRA, FRO, CTIC, CRK, VG, HL)
wrote 5 months ago: Equities opened a little weaker this morning, but by 10:00 a.m. markets had turned slightly positive … more →
24/7 Wall St. Top Analyst Calls of the Week (BK, BEAM, CTIC, CSCO, DMD, FSLR, GE, GS, RAX, S, VPRT, AAPL)
wrote 7 months ago: Each morning 24/7 Wall St. compiles a summary of the analyst upgrades, downgrades and initiations se … more →
Top Analyst Upgrades & Downgrades (ALTR, BK, BRCM, CTIC, CLWR, COP, DG, GFI, HTS, KR, NTES, NVAX, RAX)
wrote 7 months ago: These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen havin … more →
Key Secondary Offerings Impacting Stocks (AHT, CTIC, SYNM, SKT)
wrote 11 months ago: No money was injured while filming The impact of secondary offerings is being felt this morning. So … more →
Rethinking Cell Therapeutics... As An Acquirer? (CTICD)
wrote 1 year ago: Cell Therapeutics, Inc. (NASDAQ: CTICD) has long been a controversial stock. It has brought many re … more →
BioWatch: Cell Therapeutics Versus FDA, Before ASCO (CTICD)
wrote 1 year ago: Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock … more →
Have your say. Start a blog.
See our free features →
